Many security teams are still playing catch up on the risks introduced by technologies that were rapidly implemented and poorly vetted during the pandemic, while also being forced to stretch resources to counter increasingly frequent sophisticated attacks. As we edge closer to the reality of hybrid work, it’s critical that security teams begin rigorously preparing.
As pharmaceutical companies and healthcare organizations turn their attention from the development to the deployment of coronavirus vaccines, well-resourced cybercriminals are hotly following suit. The vaccine supply chain is rife with logistical complexities making the enormously valuable data on the various vaccines deeply attractive to threat actors. In fact, cybercriminals are already attempting to steal vaccine formulas and disrupt operations.